PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

2 proteins compete for 1 port on a growth factor; 1 promotes metastasis, the other blocks it

Rivals' relative expression levels in cancer cells could be biomarkers for prognosis, treatment

2014-01-23
(Press-News.org) Contact information: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
2 proteins compete for 1 port on a growth factor; 1 promotes metastasis, the other blocks it Rivals' relative expression levels in cancer cells could be biomarkers for prognosis, treatment

HOUSTON – Consider two drivers, each with a key that fits the same car. Driver 1 wants simply to turn on the ignition and leave the vehicle idling, ready and waiting to roll. Driver 2 wants to take it on a destructive joy ride.

Such is the case with two proteins identified by scientists at The University of Texas MD Anderson Cancer Center that fit on to the same binding site on an important cellular growth factor receptor called FGFR2 with starkly different results.

"There is competition for binding to FGFR2 and one of the two competitors, phospholipase Cγ1 (Plcγ1), will increase cancer cell metastasis. The other protein inhibits the opportunity for this to occur," said John Ladbury, Ph.D., professor of Biochemistry and Molecular Biology.

Ladbury is senior author of a paper published Sunday online at Nature Structural & Molecular Biology that describes the competition, identifies Plγcl's role and its relationship to the metastasis-blocking growth factor receptor bound protein 2 (Grb2).

In a 2012 paper in the journal Cell, Ladbury and colleagues showed that Grb2 binds to FGFR2 and holds it in check, ready to be activated by a growth factor to signal other proteins. In performing this role, Grb2 blocks the binding of other proteins such as Plcγ1.

More Grb2, less Plcγ1 stymies metastasis

These interactions occur outside normal activation of FGFR2 by growth factors, so the protein with the highest concentration levels in the cell wins the contest to bind to FGFR, or fibroblast growth factor receptor 2, Ladbury said. "In cells with depleted Grb2 concentration, Plcγ1gets on the receptor, increasing cellular motility – equipping cells to move, escape the tumor, invade other tissue and spread."

Quantifying the relative concentration of these two proteins in a patient's tumor, Ladbury said, might be developed into reliable markers for gauging the likelihood that the cancer will spread and guide treatment decisions.

For example, an analysis of an ovarian cancer patient's initial presentation could indicate early whether chemotherapy will be needed in addition to surgery to combat metastasis. Ovarian cancer patients with low Grb2 expression levels could have an increased risk that their cancer will spread.

Trade-off matters in at least 5 cancer types

Analysis of published data on 20 cancer cell lines including lung, ovarian, kidney, breast and colon cancers, showed that a cancer's metastatic potential is linked to the relative concentration of Plcγ1 and Grb2 expression. Overexpression of Plcγ1 and low expression of Grb2 resulted in a high likelihood of metastasis, while high Grb2 and low Plcγ1 indicated a low likelihood that the cancer will spread.

Ladbury and colleagues set out to explain this relationship and its apparent effect with a series of cell line experiments that showed:

Grb2 blocks the binding of Plcγ1 to FGFR2. Both proteins connect with the same site on FGFR2, using a similar domain on each protein to connect to the growth factor receptor. Binding to FGFR2 activates Plcγ1. Overexpression of Plcγ1 leads to increased invasion of other tissues, a vital step in metastasis.

All of this action occurs in the cell's stable state, or homeostasis, before a growth factor stimulates FGFR2 into action, which is what made the team's 2012 finding so striking. The domain (SH3) that each protein uses to connect to FGFR2 is not used in normal signaling.

FGFR2 spans a cell's outer membrane, with its outer portion receiving growth factors and its inner region passing along activating signals that order other proteins to perform their functions. In this case, there's no active signaling in the usual sense, Ladbury said.

Crucial events occur in background activity of cells

"That a protein can find a receptor using its SH3 domain is an entirely new idea," Ladbury said. "There's a lot of background activity in cells, just to keep them ticking over and in the past we've kind of ignored what's happening there. Now we've shown that if these background activities are perturbed, they can lead to cancer."

The Ladbury group is pursuing these studies to quantify the respective amounts of Grb2, Plcγ1 and FGFR2 in cancer cell lines to assess what levels might be prognostic. In addition they are investigating other receptors for their potential to bind SH3-domain containing proteins to build up a bigger picture of what pathways are involved in maintaining the stable state in cells.



INFORMATION:



Co-authors with Ladbury and first author Zahra Timsah, a graduate student in The University of Texas Graduate School of Biomedical Sciences, a joint program of MD Anderson and The University of Texas Health Science Center at Houston (UTHealth), are Zamal Ahmed, Ph.D., Chi-Chuan Lin, Ph.D., Fernando Melo, Ph.D., Loren Stagg, Ph.D., Paul Leonard, Ph.D, and Prince Jeyabal, Ph.D., all in the Department of Biochemistry and Molecular Biology; Jonathan Berrout, Ph.D., and Roger O'Neil, Ph.D., in the Department of Integrative Biology and Pharmacology at UTHealth, and Mikhail Bogdanov, Ph.D., of the Department of Biochemistry and Molecular Biology at UTHealth.

This research was funded by the G. Harold and Leila Y. Mathers Charitable Foundation and a grant from the U.S. National Institutes of Health (DK070950).



ELSE PRESS RELEASES FROM THIS DATE:

The $125 billion question: How will the ACA affect cancer survivors?

2014-01-23
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, ...

Looking for a 'superhabitable' world? Try Alpha Centauri B, says Astrobiology Journal

2014-01-23
New Rochelle, January 23, 2014—The search for extraterrestrial life extends far beyond Earth's solar system, looking for planets or moons outside the ...

Better eating habits, not bad economy, stabilized obesity rates

2014-01-23
All those people who've been telling us for years that we should eat more healthy foods and cut our calories – stop, take a moment, and celebrate. It appears that we actually ...

Scripps Florida scientists find regulator of amyloid plaque buildup in Alzheimer's disease

2014-01-23
JUPITER, FL – January 23, 2014 – Scientists from the Florida campus of The Scripps Research Institute have identified a critical regulator of a molecule deeply involved ...

Physical activity significantly extends lives of cancer survivors

2014-01-23
MAYWOOD, Il. – Physical activity significantly extends the lives of male cancer survivors, a new study of 1,021 men has found. During the period while the ...

NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer

2014-01-23
Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized ...

A new wrinkle in the control of waves

2014-01-23
CAMBRIDGE, Mass-- Flexible, layered materials textured with nanoscale wrinkles could provide a new way of controlling the wavelengths and distribution ...

Analysis indicates that North and tropical Atlantic warming affects Antarctic climate

2014-01-23
The gradual warming of the North and tropical Atlantic Ocean is contributing to climate change in Antarctica, a team of ...

Salmonella infection mitigates asthma

2014-01-23
Researchers from Germany have identified the mechanism by which Salmonella infections can reduce the incidence of asthma in mice. The research, which appears ahead of print in the journal ...

Palau's coral reefs surprisingly resistant to ocean acidification

2014-01-23
Marine scientists working on the coral reefs of Palau have made two unexpected discoveries that could provide insight ...

LAST 30 PRESS RELEASES:

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

[Press-News.org] 2 proteins compete for 1 port on a growth factor; 1 promotes metastasis, the other blocks it
Rivals' relative expression levels in cancer cells could be biomarkers for prognosis, treatment